Liver damage from stress and aging might be reversible reveals study
HQ Team July 19, 2024: Researchers at Duke University have gained some new insights into age-related degeneration of liver. In an animal experiment,.
Drugs
Health
Medical
Drugs
Health
Pharma
Akero Therapeutics says mid-stage trials on drug for fatty liver disease positive
HQ Team March 4, 2024: US-based Akero Therapeutics, Inc., announced its mid-trial of a drug to treat fatty liver disease met its primary.
Drugs
Medical
Pharma
Gilead buys CymaBay for $ 4.3b to expand its liver portfolio
HQ Team February 13, 2024: Gilead Sciences is buying CymaBay Therapeutics for $4.3 billion, to access its portfolio of drugs for liver and.
Drugs
Health
Pharma
Egypt close to ending hepatitis C, gets WHO ‘gold tier’ status
HQ Team October 9, 2023: Egypt has been granted a “gold tier” status by the WHO for providing 93% of those diagnosed with.
Drugs
Health
Pharma
FDA applies brakes on Merck’s multiple sclerosis drug tests
HQ Team April 13, 2023: Merck KGaA announced the USFDA had put a hold on the initiation of new patients to test its.
Drugs
Health
Pharma
Cure for nonalcoholic fatty liver disease may be near: Scientists say
HQ Team April 11, 2023: Scientists are close to developing a human treatment for nonalcoholic fatty liver after successfully developing a compound tested.